menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Italfarmaco Updates On Givinostat For Duchenne MD

    BUSINESSWIRE

    QuVa Pharma Acquires LogicStream Health

    PR NEWSWIRE

    PANTHERx Partners With ITF Therapeutics For DUVYZAT Distribution

    PR NEWSWIRE

    US FDA approves Italfarmaco`s drug for Duchenne muscle-wasting disorder

    REUTERS

    FDA Approves Nonsteroidal Treatment for Duchenne Muscular Dystrophy

    PR NEWSWIRE

    Results from Italfarmaco Pivotal Phase 3 EPIDYS Study of Givinostat in DMD

    BUSINESSWIRE

    Italfarmaco Group Receives EMA Validation of MAA for Givinostat

    BUSINESSWIRE

    Italfarmaco Completes FDA Submission of NDA for Givinostat in DMD

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.